American Academy of Pediatrics (AAP). Committee on Infectious Diseases.
Recopilado por Carlos Cabrera Lozada. Miembro Correspondiente Nacional, ANM puesto 16. ORCID: 0000-0002-3133-5183. 07/01/2022
Vaccines are safe and effective in protecting individuals and populations against infectious diseases. New vaccines are evaluated by a long-standing, rigorous, and transparent process through the US Food and Drug Administration and the Centers for Disease Control and Prevention (CDC), by which safety and efficacy data are reviewed before authorization and recommendation.
The American Academy of Pediatrics (AAP) recommends the following related to coronavirus disease 2019 (COVID-19) vaccine in children and adolescents:
- The AAP recommends COVID-19 vaccination for all children and adolescents 5 years of age and older who do not have contraindications using a COVID-19 vaccine authorized for use for their age.
- Any COVID-19 vaccine authorized through Emergency Use Authorization or approved (through a Biologics License Application) by the US Food and Drug Administration, recommended by the CDC, and appropriate by age and health status can be used for COVID-19 vaccination (primary series, additional doses, or booster doses) according to CDC guidelines for children and adolescents.
- Children with previous infection or disease with SARS-CoV-2 should receive COVID-19 vaccination, according to CDC guidelines.